Koers Opexa Therapeutics Inc Nasdaq
Aandelen
US68372T3014
Biotechnologie & Medisch Onderzoek
Recentste transcriptie over Opexa Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 01-06-21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Joshua Schafer
BRD | Director/Board Member | 53 | 17/11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 126 mld. | |
+24,67% | 118 mld. | |
+22,97% | 27,87 mld. | |
-17,74% | 20,95 mld. | |
-16,31% | 16,92 mld. | |
-15,21% | 16,18 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,79 mld. | |
+54,50% | 14,08 mld. |